Research Article

Construction of a Cuprotosis-Related Gene-Based Model to Improve the Prognostic Evaluation of Patients with Gastric Cancer

Table 1

General clinical data of the two groups of patients.

CovariatesTypeTotalTestTrain value

Age≤65163 (43.94%)84 (45.41%)79 (42.47%)0.7438
Age>65205 (55.26%)101 (54.59%)104 (55.91%)
AgeUnknown3 (0.81%)0 (0%)3 (1.61%)
GenderFemale133 (35.85%)71 (38.38%)62 (33.33%)0.3655
GenderMale238 (64.15%)114 (61.62%)124 (66.67%)
GradeG110 (2.7%)4 (2.16%)6 (3.23%)0.7102
GradeG2134 (36.12%)65 (35.14%)69(37.1%)
GradeG3218 (58.76%)112 (60.54%)106 (56.99%)
GradeUnknown9 (2.43%)4 (2.16%)5 (2.69%)
StageStage I50 (13.48%)24 (12.97%)26 (13.98%)0.7072
StageStage II111 (29.92%)52 (28.11%)59 (31.72%)
StageStage III149 (40.16%)80 (43.24%)69 (37.1%)
StageStage IV38 (10.24%)20 (10.81%)18 (9.68%)
StageUnknown23 (6.2%)9 (4.86%)14 (7.53%)
TT118 (4.85%)7 (3.78%)11 (5.91%)0.7283
TT278 (21.02%)38 (20.54%)40 (21.51%)
TT3167 (45.01%)83 (44.86%)84 (45.16%)
TT4100 (26.95%)53 (28.65%)47 (25.27%)
TUnknown8 (2.16%)4 (2.16%)4 (2.15%)
MM0328 (88.41%)165 (89.19%)163 (87.63%)0.689
MM125 (6.74%)11 (5.95%)14 (7.53%)
MUnknown18 (4.85%)9 (4.86%)9 (4.84%)
NN0108 (29.11%)50 (27.03%)58 (31.18%)0.2444
NN197 (26.15%)45 (24.32%)52 (27.96%)
NN274 (19.95%)40 (21.62%)34 (18.28%)
NN374 (19.95%)44 (23.78%)30 (16.13%)
NUnknown18 (4.85%)6 (3.24%)12 (6.45%)